TY  - GEN
AU  - Horáková,D
AU  - Kýr,M
AU  - Havrdová,E
AU  - Doležal,O
AU  - Lelková,P
AU  - Pospíšilová,L
AU  - Bergsland,N
AU  - Dwyer,M G
AU  - Cox,J L
AU  - Hussein,S
AU  - Seidl,Z
AU  - Vaněčková,M
AU  - Krásenský,J
AU  - Zivadinov,R
TI  - Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study
SN  - 0015-5500
PY  - 2011///0627
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Adult
KW  - Anti-Inflammatory Agents
KW  - Apolipoprotein E4
KW  - genetics
KW  - Atrophy
KW  - pathology
KW  - Azathioprine
KW  - Brain
KW  - Disease Progression
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Humans
KW  - Image Processing, Computer-Assisted
KW  - Immunosuppressive Agents
KW  - Interferon beta-1a
KW  - Interferon-beta
KW  - Longitudinal Studies
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Nerve Fibers, Myelinated
KW  - Prednisone
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ER  -